NCT00584376 - Pregabalin (Lyrica) for the Treatment of Essential Tremor | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Essential Tremor

Interventions

DRUG

Pregabalin

Gradually titrated dose ranging from 75mg po bid to 225mg po bid.

DRUG

Placebo

Placebo capsules which are identical in packaging, appearance and dosing as the active capsules.

Trial Locations (8)

Medical University of South Carolina, Charleston

Emory Univ. School of Medicine, Atlanta

Medical College of Georgia, Augusta

University of South Florida, Tampa

University of Alabama at Birmingham, Birmingham

Vanderbilt, Nashville

University of Tennessee Health Science Center, Memphis

Southern Illinois U. School of Medicine, Springfield